Back

Device specific quality of life in subcutaneous versus transvenous implantable cardioverter defibrillator implantations: results from the ATLAS multi-centre randomized controlled trial

27 August 2023 (12:15 - 12:40)
Organised by: Logo
Congress Presentation Part of: Disease and symptom perceptions in cardiac arrhythmias and associated care Allied Professions in Cardiovascular Care ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Sandra Carroll

McMaster University, Hamilton (Canada)

3 More presentations in this session

Presentation thumbnail
The perceptions of disease and its symptoms compared by gender among patients with AF and their quality of life
Assistant Professor Y. Tsai (Taoyuan, TW)
Abstract Slides Video
Presentation thumbnail
Individual tailored physical training in patients with postural orthostatic tachycardia syndrome after COVID-19 - a feasibility study
Miss A. Svensson (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Palliative care for cardiovascular patients: description of motives for referral and actual care provided
Doctor F. Ecarnot (Besancon, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Disease and symptom perceptions in cardiac arrhythmias and associated care

The Event

Event poster

ESC Congress 2023

27 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Short- and long-term patient-reported outcomes of subcutaneous implantable cardioverter-defibrillator therapy
thumbnail
Congress Session
Late-Breaking Clinical Trials: recent advances in CIED therapies
thumbnail
Congress Session
Smaller trials, trial updates, and other studies: devices, cardiac arrest and atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources